CHMP reccomends Bayer’s Eye medicine for approval in EU
The European Committee for Medicinal Products for Human Use (CHMP) has recommended Bayer’s aflibercept solution for injection into the eye…
Pharmaceuticals, Biotechnology and Life Sciences
The European Committee for Medicinal Products for Human Use (CHMP) has recommended Bayer’s aflibercept solution for injection into the eye…
The Japanese Ministry of Health, Labor and Welfare (MHLW) has approved in Japan Bayer’s oral Factor Xa inhibitor Xarelto (rivaroxaban) for the treatment…
Switzerland-based Novartis has today appointed Dr. James E. Bradner, physician-scientist from Dana-Farber Cancer Institute and Harvard Medical School, as President of the…
Novartis has announced the launch of Novartis Access, a portfolio of 15 medicines to treat chronic diseases in low- and…
Amgen and Allergan plc. announced on Wednesday that a Phase 3 study of biosimilar candidate ABP 215 met its primary…
FDA is warning health care professionals about the risk for dosing errors with the intravenous antibacterial drug Avycaz (ceftazidime and…
US presidential candidate from Democratic party, Hilary Clinton, has announced to make a plan about pricing medicine. After the news spread…
Biofrontera, the biopharmaceutical company focusing on sun-induced skin cancer, has announced that preliminary long-term results of the Phase III trial for…
Allergan, a Dublin-headquartered pharmaceutical company, confirmed on Monday that it has filed an Abbreviated New Drug Application (ANDA) with the…
You must be logged in to post a comment.